Executive record
Alpha ID: alpha:person:timothy-a-gray-atexVersion: public-0As of: 2026-09-29
Key Claims
Biography
Mr. Gray was appointed Chief Financial Officer of Anterix in June 2014, having previously served as SVP and CFO of MedImmune, Inc. (an AstraZeneca subsidiary) and in finance roles at AOL and Nextel, starting his career at Deloitte & Touche LLP.
Alpha editorial summary written from the cited sources below. It does not change any Claim on this record.
Executive career
- 2024 to end not publishedExecutive title: Chief Financial Officer · Organization not publishedATEX DEF 14A executive officers
Claims
Conflicts and accountability
Alpha has not published independence, related-party, proceedings or disciplinary Claims for this record. This is not a finding that none exist.
Only disclosed facts and public registers appear here. Executive records carry no credit, personal litigation, background screening or underwriting views. None observed is not a clearance.
Evidence, history and coverage
Additional published Claims
Published evidence records
2 evidence records, matching Agent View. Records may refer to different locations or observations in the same document. This count is not a count of independent corroborating sources.
ATEX DEF 14A executive officers
sec filing · Source published: Jul 3, 2024 · Retrieved: May 14, 2026
Supports 5 claims
- AI and ML experience: AI and ML experience: not identified in the cited filing · Claim reviewed: May 14, 2026
- Cybersecurity experience: Cybersecurity experience: not identified in the cited filing · Claim reviewed: May 14, 2026
- Executive company: Executive at Anterix Inc. · Claim reviewed: May 14, 2026
- Executive title: Executive title: Chief Financial Officer · Claim reviewed: May 14, 2026
- Technology background: Technology background: not identified in the cited filing · Claim reviewed: May 14, 2026
ATEX executive roster source
sec filing · Source published: Date unavailable · Retrieved: May 3, 2026
Supports 5 claims
- AI expertise: AI expertise: not identified in the cited filing · Claim reviewed: May 3, 2026
- AI governance relevance: AI governance relevance: not identified in the cited filing · Claim reviewed: May 3, 2026
- Executive company: Executive at Anterix Inc. · Claim reviewed: May 14, 2026
- Executive function: Finance Controls (CFO) · Claim reviewed: May 3, 2026
- Executive title: Executive title: Chief Financial Officer · Claim reviewed: May 14, 2026
No published record changes are available in this projection.
Identity
unclaimed
Evidence
corroborated
Evaluation
Unknown
Monitoring
Unknown
Authority
Unknown
Freshness
Observed 2026-09-29
- Biography
- published
- Board service
- not observed
- Executive career
- published
- Education and qualifications
- not observed
- Compensation
- not observed
- Conflicts and accountability
- not observed
- Background screening
- out of scope

